INTESTINE Vol.25 No.04 ( Dec, 2021)

Thesis List

• 0 Editorial
  Shin-ei Kudo

• 1 History and current status of 0-IIc colorectal lesions
  Shin-ei Kudo

• 2 History and present status of the pathology of depressed type (0-IIc) colorectal cancer
  Hiroshi Kawachi

• 3-1-1 Current status and problem of depressed-type early colorectal cancer: From the perspective of an academic hospital
  Hidenori Tanaka

• 3-1-2 Current status and signifi cance of and issues related to type IIc colorectal lesions in each hospital: At the core hospital level
  Osamu Tsuruta

• 3-2-1 Is the concept of IIc cancer still universal even three decades later?
  Satoru Tamura

• 3-2-2 Explaining the basis for the existence of depressed-type colorectal tumors at the time of clinical diagnosis of colorectal lesions
  Takeshi Terai

• 3-3-1 Current status, significance and issues of IIctype colorectal cancer in each field: Significance of pericryptal fibroblast and phenotypic expression in tumor development
  Takashi Yao

• 3-3-2 Significance of type IIc lesions -- from the point of view of residual intramucosal component of pT1 colorectal carcinoma
  Yoichi Ajioka

• 4-1 What relevance has magnifying colonoscopy to IIc neoplastic lesion? From the view-point of pit pattern
  Takahiro Fujii

• 4-2 Clinical significance of narrow-band imaging for colorectal depressed lesions
  Wataru Sano

• 4-3 Endocytoscopy and artificial intelligence for depressed-type colorectal cancer
  Masashi Misawa

• 5 Features of depressed-type colorectal cancer -- Analysis of colorectal lesions registered in the survey of the 69th Japanese Society for Cancer of the Colon and Rectum (JSCCR)
  Fumio Ishida

• 6 Investigating inter-observer and -generation gaps between endoscopic quality indicators for depressed type of colorectal tumor
  Hiro-o Yamano

Series List

• 7-1 Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
  Taku Kobayashi

  TOPICS

• 7-2 Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission
  Miyuki Kaneshiro

  TOPICS

• 8 Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
  Eiji Harada